Studies have shown that Tregs, a unique subpopulation of CD4+T cells, hinder the antitumor effects of CTLs generated by oHSV-induced immunogenic cell death (ICD) of tumor cells, thereby leading to tumor progression 57, 58. This evidence concerns the gene CD4 and neoplasm.